Benefits of cannabis in treating lower urinary tract symptoms
Canadian Urological Association Journal · 20.08.2026 · 20 (12)
DOI: 10.5489/cuaj.9478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Urological Association Journal, online erschienen am 20.08.2026. Verfasst von Alan Cheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, McMaster University, Hamilton, ON, Canada.
Abstract (Originalsprache)
Introduction
Anticholinergics and β3-agonists remain the mainstay for bladder dysfunction but are limited by side effects and poor adherence. Cannabinoids are a potential alternative given receptor distribution in bladder control pathways. Early studies suggested that cannabis may demonstrate benefits in overactive bladder (OAB) and lower urinary tract symptoms (LUTS), but findings are limited by small sample sizes and cross-sectionality. This review investigates the therapeutic utility of cannabis and its impact on LUTS.
Methods
This scoping review was conducted following Cochrane and PRISMA guidelines. Eligible studies included adults with OAB symptoms due to neurogenic disease, benign prostatic hyperplasia (BPH), or cystitis, treated with cannabis vs. placebo, no treatment, or active therapies. Outcomes included urinary function and quality of life. Databases searched included MEDLINE, EMBASE, and CENTRAL. Non-English studies were excluded.
Results
From 998 abstracts, 31 full-text articles were reviewed and 12 were included. Studies showed consistent evidence on the effectiveness of cannabis-based therapies for managing LUTS, particularly in patients with multiple sclerosis (MS). Cannabis interventions, including THC, CBD, and combined formulations, showed some improvements in incontinence episodes, frequency, and quality-of-life measures. Mild adverse effects, including dizziness and dry mouth, were common (2−18%) and sometimes led to treatment discontinuation. Nine of 12 studies were done on MS populations, and only three studies were randomized controlled trials.
Conclusions
Evidence for the benefits of cannabis in treating LUTS is limited and largely observational. While preliminary findings are encouraging, randomized trials focusing on patient-centered outcomes are needed to clarify its role in clinical practice.
Autor:innen und Institutionen
- Division of Urology, Department of Surgery, McMaster University, Hamilton, ON, Canada.
Zitieren
APA
Cheng, A., Kim, J., & Blankstein, U. (2026). Benefits of cannabis in treating lower urinary tract symptoms. Canadian Urological Association Journal, 20(12). https://doi.org/10.5489/cuaj.9478
Vancouver
Cheng A, Kim J, Blankstein U. Benefits of cannabis in treating lower urinary tract symptoms. Canadian Urological Association Journal. 2026;20(12). doi:10.5489/cuaj.9478
BibTeX
@article{Cheng2026,
author = {Cheng, Alan and Kim, John and Blankstein, Udi},
title = {Benefits of cannabis in treating lower urinary tract symptoms},
journal = {Canadian Urological Association Journal},
year = {2026},
volume = {20},
number = {12},
doi = {10.5489/cuaj.9478}
}
EUVIMED